Skip to main content
Premium Trial:

Request an Annual Quote

Masao Yoneyama, Edward Erickson

Premium
Affymetrix has appointed Masao Yoneyama as general manager of its Japanese operations.

He comes to Affy from Daiichi Pure Chemicals, where he was the general manager of business development.

Yoneyama has a BS in chemistry and an MS and PhD in toxicology from Utah State University.

 

 
BioTrove has appointed Edward Erickson to its board of directors, which BioTrove said “reflects [its] increased emphasis on diagnostics and services.”
 

Erickson is chairman of Immunicon. He has BS and MS degrees from the Illinois Institute of Technology and an MBA from the Harvard Business School

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.